Insulet Corporation (PODD)
Insulet Corporation Revenues: 47.75M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
PODD Revenues Rankings
| Overall | 34th percentile | 2886 of 4432 |
| Sector | 58th percentile | 196 of 471 in Healthcare |
| Industry | 60th percentile | 27 of 68 in Medical Instruments & Supplies |
PODD Revenues Range, Past 5 Years
| Minimum | 3.212M | Jun 2007 |
| Maximum | 47.75M | Mar 2012 |
| Average | 20.52M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these PODD related companies
PODD News
Canaccord Genuity Reiterates a 'Buy' on Insulet Corporation (PODD); Solid Q1; Gen2 Pod Still Awaiting FDA Clearance
May 10, 10:42AM Street Insider
May 10, 10:42AM Street Insider
$PODD 200 Day SMA Cross - Price crossed above 200 day SMA (17.9438). Confirmed by volume.
about 22 days ago by TradeIdeasQuant
about 22 days ago by TradeIdeasQuant
Listen to $PODD Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3kl2
about 22 days ago by earningscast
about 22 days ago by earningscast
Insulet Corporation to Present at the 11th Annual JMP Securities Research Conference
Apr 30, 4:15PM Marketwire
Apr 30, 4:15PM Marketwire
Insulet Corporation to Report First Quarter 2012 Financial Results on May 9, 2012
Apr 26, 4:15PM Marketwire
Apr 26, 4:15PM Marketwire
Avondale Partners Starts Insulet Corporation (PODD) at Market Outperform
Apr 18, 11:26AM Street Insider
Apr 18, 11:26AM Street Insider
Rodman & Renshaw Upgrades Insulet Corporation (PODD) to Market Outperform
Apr 18, 11:24AM Street Insider
Apr 18, 11:24AM Street Insider
$PODD 200 Day SMA Cross - Price crossed below 200 day SMA (18.3018). Confirmed by volume.
about 44 days ago by TradeIdeasQuant
about 44 days ago by TradeIdeasQuant
$PODD 200 Day SMA Cross - Price crossed above 200 day SMA (18.3018). Confirmed by volume.
about 44 days ago by TradeIdeasQuant
about 44 days ago by TradeIdeasQuant
We exited $PODD @ 19.58 for +3.65% gain. will post chart later. No new positions
about 65 days ago by ScholzCapital
about 65 days ago by ScholzCapital
Correction: We exited $UTX and $MNRO today for profit. Still Long $PODD and $RIGL
about 66 days ago by ScholzCapital
about 66 days ago by ScholzCapital
We exited $PODD and $RIGL both for profit. will post charts later
about 66 days ago by ScholzCapital
about 66 days ago by ScholzCapital
We exited $SMP and $FCFS (MOC) for gains. We added 1st unit Longs in: $MNRO $PODD
about 69 days ago by ScholzCapital
about 69 days ago by ScholzCapital
Insulet Corporation to Present at the Leerink Swann Global Healthcare Conference
Feb 13, 11:44AM Marketwire
Feb 13, 11:44AM Marketwire
Feltl and Company Maintains Insuletoration at Buy, Raises PT from $18.6 to $22.1
Feb 13, 8:18AM Benzinga
Feb 13, 8:18AM Benzinga
Jefferies Maintains a 'Buy' on Insulet Corp (PODD)Waiting for the Next Gen Pod
Feb 10, 1:29PM Street Insider
Feb 10, 1:29PM Street Insider
Canaccord Genuity Reiterates a 'Buy' on Insulet (PODD); Mixed Results - NDI Integration Complete
Feb 10, 10:44AM Street Insider
Feb 10, 10:44AM Street Insider
Listen to $PODD Q4 2011 earnings call - live at 05:00 PM, ondemand after - http://stks.co/2KwX
about 112 days ago by earningscast
about 112 days ago by earningscast
Canaccord Genuity on Life Sciences/Biomedical Devices and Services: Take on Q4 and Beyond
Feb 07, 8:39AM Street Insider
Feb 07, 8:39AM Street Insider
Insulet Corporation to Report Fourth Quarter and Full Year 2011 Financial Results on February 9, 2012
Feb 03, 12:15PM Marketwire
Feb 03, 12:15PM Marketwire
Canaccord Genuity: Prompt follow-up on Insulet questions/responses from FDA could mean approval as early as Q1/12. $PODD
about 171 days ago by abubnic
about 171 days ago by abubnic
Canaccord Genuity "buy" rating on $PODD. Insulet filed official response to FDA questions on 11/21; expects updated FDA response by YE/11
about 171 days ago by abubnic
about 171 days ago by abubnic
$PODD http://chart.ly/jakb2kg Could be a gap-fill. Needs volume. MACD/RSI curling. On radar.
about 291 days ago by Judy_G
about 291 days ago by Judy_G
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PODD | 18.43 | -0.08 | -0.43% | 880.71M |
| PNY | 30.30 | +0.63 | +2.12% | 2.146B |
| PNX | 1.61 | -0.02 | -1.23% | 189.59M |
| PNW | 49.35 | +0.50 | +1.02% | 5.337B |
| PLX | 6.42 | +0.07 | +1.10% | 576.71M |
| PLUS | 31.43 | -0.27 | -0.85% | 255.50M |
| PLUG | 1.17 | +0.02 | +1.62% | 43.49M |
| PLT | 30.08 | -0.46 | -1.51% | 1.313B |
| PLPC | 54.81 | -1.51 | -2.68% | 292.14M |
| PLOW | 12.78 | -0.12 | -0.93% | 285.48M |
